Thrivent Financial for Lutherans »

Halozyme Therapeutics shares owned by Thrivent Financial for Lutherans

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Thrivent Financial for Lutherans from 13F filings

Historical chart of Thrivent Financial for Lutherans investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Thrivent Financial for Lutherans consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Thrivent Financial for Lutherans

Quarter filed Position value Share count Share price at filing
2023-09-30 $77M 2.0M 38.20
2023-06-30 $75M 2.1M 36.07
2023-03-31 $41M 1.1M 38.19
2022-12-31 $52M 920k 56.90
2022-09-30 $52M 1.3M 39.54
2022-06-30 $58M 1.3M 44.00
2022-03-31 $59M 1.5M 39.88
2021-12-31 $43M 1.1M 40.21
2021-09-30 $31M 753k 40.68
2021-06-30 $35M 768k 45.41
2021-03-31 $31M 734k 41.69
2020-12-31 $53M 1.2M 42.71
2020-09-30 $31M 1.2M 26.28
2020-06-30 $32M 1.2M 26.81
2020-03-31 $21M 1.2M 17.99
2019-12-31 $21M 1.2M 17.73
2019-09-30 $60M 3.9M 15.51
2019-06-30 $65M 3.8M 17.18
2019-03-31 $59M 3.7M 16.10
2018-12-31 $52M 3.6M 14.63
2018-09-30 $57M 3.1M 18.17
2018-06-30 $39M 2.3M 16.87